- Home
- CRDF vs GTE Comparison
CRDF vs GTE Comparison
Compare CRDF & GTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- GTE
- Stock Information
- Founded
- CRDF 1999
- GTE 2003
- Country
- CRDF United States
- GTE Canada
- Employees
- CRDF N/A
- GTE N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- GTE Oil & Gas Production
- Sector
- CRDF Health Care
- GTE Energy
- Exchange
- CRDF Nasdaq
- GTE Nasdaq
- Market Cap
- CRDF 144.4M
- GTE 139.0M
- IPO Year
- CRDF N/A
- GTE N/A
- Fundamental
- Price
- CRDF $2.05
- GTE $3.87
- Analyst Decision
- CRDF Strong Buy
- GTE
- Analyst Count
- CRDF 5
- GTE 0
- Target Price
- CRDF $11.10
- GTE N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- GTE 229.3K
- Earning Date
- CRDF 11-06-2025
- GTE 11-03-2025
- Dividend Yield
- CRDF N/A
- GTE N/A
- EPS Growth
- CRDF N/A
- GTE N/A
- EPS
- CRDF N/A
- GTE N/A
- Revenue
- CRDF $545,000.00
- GTE $621,677,000.00
- Revenue This Year
- CRDF N/A
- GTE $5.03
- Revenue Next Year
- CRDF N/A
- GTE N/A
- P/E Ratio
- CRDF N/A
- GTE N/A
- Revenue Growth
- CRDF N/A
- GTE N/A
- 52 Week Low
- CRDF $1.90
- GTE $3.34
- 52 Week High
- CRDF $5.64
- GTE $8.19
- Technical
- Relative Strength Index (RSI)
- CRDF 36.50
- GTE 42.62
- Support Level
- CRDF $2.03
- GTE $3.78
- Resistance Level
- CRDF $2.27
- GTE $4.12
- Average True Range (ATR)
- CRDF 0.12
- GTE 0.17
- MACD
- CRDF 0.04
- GTE 0.01
- Stochastic Oscillator
- CRDF 31.91
- GTE 16.35
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.